DNA methylation increases the binding of transcription factor TFAP2A to B1, leading to suppressed gene expression; low methylation in the NRBP1 promoter region reduces TFAP2A binding, thereby increasing NRBP1 expression, which may contribute to the development of gout (Zhu et al., 2017). The gene discussed is TFAP2A; the disease is gout.